Le Lézard2d
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
AZoLifeSciences on MSN3d
Gene Delivery Systems: Viral vs. Non-Viral Vectors
This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
Medscape4d
Does COVID-19 Vaccination Affect Thyroid Health Long Term?
COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...
Business Insider9d
Appointment of Joint Corporate Broker and Joint Financial Adviser
OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated ...